Safety and surveillance issues in stem cell marketing
ISBT Education. Sipp D. Jun 3, 2018; 218843 Topic: Safety and adverse events
Douglas Sipp
Douglas Sipp
This content is exclusively available for members.

You may become an ISBT member here.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:
- Gain insight into the prevalence of direct-to-consumer online stem cell clinics
- Discuss issues related to direct-to-consumer stem cell clinics
Code of conduct/disclaimer available in General Terms & Conditions

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies